Completed PHASE2 INTERVENTIONAL 3-arm NCT00266461

A Tolerability and Efficacy Study of TU-100 For The Treatment of Postoperative Ileus

A Randomized, Controlled, Open-Label Tolerability And Efficacy Study Of TU-100 For The Treatment Of Postoperative Ileus In Patients Undergoing Laparotomy For Large Bowel Resection

Sponsor: Tsumura USA

Conditions Postoperative Ileus

Interventions Daikenchuto Extract Granules (TU-100)

Updated 8 times since 2017 Last updated: Jul 11, 2013 Started: Dec 31, 2005 Primary completion: Jan 31, 2008 Completion: Jan 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Postoperative Ileus, this trial is completed. The trial is conducted by Tsumura USA and has accumulated 8 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Apr 2022 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Apr 2022 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Dec 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tsumura USA

Data source: Tsumura USA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• St Louis, United States